The Beyblade X line is getting new starter pack sets, and there’s the now-available Beyblade X BX-10 Extreme Stadium. ADK Emotions and Hasbro revealed that the 2025 Beyblade X World Championship ...

In response to a deal cementing about $11 billion in lost value since the 2022 sale, X CEO Linda Yaccarino posted, “The future could not be brighter.” Today’s tweet also didn’t mention his ...

More than 56,000 people briefly reported issues accessing Elon Musk’s social media platform X just before 3 p.m. EDT on Friday, the second-straight day users indicated problems with the platform ...

LONDON, March 27 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab shares have fallen 25% so far in March and are on track for their biggest monthly drop since July 2002, as investor worries ...

GDANSK/LONDON, March 28 (Reuters) - Bank of America analysts on Friday said Novo Nordisk (NOVOb.CO), opens new tab may miss first-quarter expectations, as sales of its blockbuster Wegovy and ...

The Novo Nordisk Foundation’s project to explore food processing has created some controversy of late. Initially, the project was framed as ‘the next generation’ of the ‘Nova’ classification, with its ...

Elon Musk said Friday his artificial intelligence startup, xAI, has acquired his social media platform, X, for $33 billion in an all-stock transaction. Musk announced the deal in a Friday post ...

Novo Nordisk announced Monday a $2 billion deal with a Chinese company making a drug in the same GLP-1 space where the Danish company is currently the leading player. Novo Nordisk said it’s ...

Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity and diabetes drug, the company announced March 24. The drug, called ...

At 0900 GMT, SAP had a market cap of $340 billion, slightly more than Novo Nordisk, according to Reuters calculations using LSEG Workspace data.SAP is Euro Software maker SAP unseats Novo Nordisk ...

German tech giant SAP SE rose to the throne of Europe's biggest public company, surpassing the market capitalisation of the Danish drug maker Novo Nordisk. The multinational software company ...

The popularity of Novo Nordisk's Ozempic and Wegovy has attracted competitors and created supply constraints. Novo Nordisk's next-generation weight loss drug disappointed investors in Phase III ...